Gabapentin Versus Transdermal Fentanyl Matrix for Chronic Neuropathic Pain
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
Gabapentin is a first line medication and fentanyl is second line medication in neuropathic
pain. But, there is no head to head study on the efficacy of those medication in neuropathic
pain.
The hypothesis of this study is that the efficacy of the transdermal fentanyl matrix is not
inferior to the gabapentin in neuropathic pain.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Asan Medical Center Chonnam National University Hospital Chung-Ang University Hosptial, Chung-Ang University College of Medicine Dankook University Inje University Seoul National University Bundang Hospital